Clinical Trial Update: Imiquimod and Pembrolizumab in Treating Patients With Stage IIIB-IV Melanoma [EARLY_Phase 1]

View source ↗

Summary

An early Phase 1 trial evaluating the combination of imiquimod and pembrolizumab in patients with stage IIIB-IV melanoma has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Imiquimod (imiquimod)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Mayo Clinic | Conditions: Metastatic Melanoma, Stage IIIB Cutaneous Melanoma AJCC v7 | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2026-03-19